GE launched today Healthymagination, a six-year initiative that will redirect half of its $1 billion healthcare R&D budget toward driving down the cost of healthcare while boosting access to improved care through technology and service innovations in the U.S. and around the world.
GE launched today Healthymagination, a six-year initiative that will redirect half of its $1 billion healthcare R&D budget toward driving down the cost of healthcare while boosting access to improved care through technology and service innovations in the U.S. and around the world.
GE's chairman and CEO Jeff Immelt announced in a press conference the company's commitment to spend $3 billion in R&D in the next six years to support the new objectives that he says will be met in part through the development of lower cost technologies and a new electronic medical record system to ensure that providers make the best use of medical technologies and available practices.
The initiative is modeled on the company's "Ecomagination" program begun four years ago with the goal of developing and implementing ecofriendly products and services.
Immelt specifically cited low-cost digital x-ray machines, portable ultrasound systems, low-dose CT scanners, and more affordable cardiac equipment as ways to deliver on these promises. Another $2 billion will be provided to finance the acquisition of healthcare IT and improve access to care in rural and underserved areas. GE also committed $1 billion for partnerships, patient education, and other services.
The $500 million per year earmarked for Healthymagination technologies will account for half of the $1 billion GE plans to spend on R&D in each of the next six years, said John Dineen, CEO of GE Healthcare in an interview with Diagnostic Imaging SCAN, a business publication affiliated with Diagnostic Imaging.
He noted that GE's R&D budget will increase in the next four or five years. Funding for Healthymagination projects will originate from this existing, incrementally growing pot of money, according to Immelt.
"What we are really going to be doing is putting our ideas through screens and saying, ‘Hey, is this product going to make a difference from a quality, cost, or access standpoint?' In making that judgment, we want to be sure that we are not simply trading off one for the other," Dineen said.
Funds will go toward producing by 2015 at least 100 innovations that lower cost, increase access, and improve healthcare quality by 15%, Immelt said. The company will share its expertise in management with providers and others in healthcare to bolster productivity, cut costs and improve quality of care.
Among the four priorities of the new initiative is acceleration of the development of healthcare information technology. The other three will target the design and production of high-tech yet affordable healthcare products, broaden access to underserved patients, and support consumer-driven health. Some of the effort from this initiative will be directed internally to expand employee health efforts by creating new wellness and healthy worksite programs, while keeping cost increases below the rate of inflation.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
New AI-Enabled Portable Ultrasound May Facilitate 50 Percent Reduction in Cardiac Imaging Scan Time
March 28th 2025Artificial intelligence (AI)-powered measurement capabilities provide key features with the Compact Ultrasound 5500CV device, which was unveiled at the American College of Cardiology (ACC) conference.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers
March 25th 2025Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.